Gadobutrol Injection/API

• 

Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimited is mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/￥ revenue in 2019. Beiluprovides complete Contrast Media products Include ct contrast medium, mri contrast medium, gadopentetate dimeglumine,etc, and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.

In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contrast Media used in various parts of the body lesion (including the brain and spinal cord) MRI imaging and angiography examination. Its macrocyclic nature ensures it is well-tolerated with a good safety profile for MRI Contrast. As a professional contrast media manufacturer, Beilu can provide you with the high concentration gadobutrol gadovistthat leads to a better image with lower volume.

Product name: Gadobutrol Injection
Generic name: Gadobutrol Injection
Type: Injectable Contrast Media for MRI, Macrocyclic Contrast Media
Ingredients: Gadobutrol
Specification: Gadovist 7.5 ml - 4.5354 g, injection gadobutrol 0.1 ml
Administration: Intravenous administration only.
Adverse reactions: See the details from the package insert.

Shelf life: 24 months
Indication of Gadopentetate Dimegumine Injection
Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.

Precautions of Gadopentetate Dimegumine Injection
1. Use with caution in patients with severe kidney damage, epilepsy, hypotension, asthma and other allergic respiratory diseases and those with allergic tendencies.
2. Pay attention to avoid the extravasation of the liquid during the gadobutrol injection uses so as to prevent tissue pain.
3. The serum iron and bilirubin levels of some patients will increase slightly after medication, but they are asymptomatic and can return to normal within 24 hours.
4. Pregnant women and breastfeeding women should use it with caution. Animal experiments show that a small amount of medicine liquid enters the milk.
5. The effective enhancement time of this product is 45 minutes. MRI examination should be performed immediately after intravenous injection.
6. The remaining medicine liquid after one examination should not be used again.
7. When applying the gadovist doses, follow the relevant safety regulations in magnetic resonance imaging.
8. GBCAs should be used with caution. When plain scan MRI cannot obtain the corresponding vital diagnostic information, GBCAs can be used, and the lowest approved dose is used as much as possible.
9. Gadolinium deposition

Current evidence shows that after repeated use of macrocyclic gbca, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic gadolinium.

The clinical significance of brain gadolinium deposition is unclear.

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

If you have interest, we will offer gadobutrol injection uses and gadovist price lists to you.

Other supplier products

	Calcobutrol	Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Quality standard: CP Characteristics: White or off-wh...
	Gadopentetate Dimeglumine Injection/API	Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ...
	Anti-Diabetic Drugs	The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th...
	CT/X-Ray Contrast Media	The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres...
	Iopamidol Injection	Iopamidol Injectionis the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilufirstly launched and li...

Same products

	Spectinomycin Hydrochloride Soluble Powder 50% 200g	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Product Name: Spectinomycin Hydrochloride Soluble PowderMain ingredients: Spectinomycin hydrochlo...
	Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble Powder 10% 200g	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Product Name: Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble PowderMain Ingredi...
	Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble Powder 10% 500g	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Product Name: Spectinomycin Hydrochloride and Lincomycin Hydrochloride Soluble PowderMain Ingredi...
	Sulfamonomethoxine Sodium Soluble Powder 10% 500g	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Brand Name: Shengxue Qiu KangGeneric Name: Sulfamonomethoxine Sodium Soluble PowderActive Ingredi...
	Sulfachloropyrazine Sodium Soluble Powder Supplier	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Trade Name: Shengxue Qiuling Common Name: Sulfachloropyrazine Sodium Soluble Powder Main Ingredie...